版本:
中国

BRIEF-U.S. FDA says approves new eczema drug Dupixent

March 28 U.S. FDA:

* FDA approves new eczema drug Dupixent

* FDA granted the application for Dupixent priority review and breakthrough therapy designation

* FDA granted the approval of Dupixent to Regeneron Pharmaceuticals Inc Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐